EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer

Dig B Mahat, Heena Kumra, Sarah A Castro, Emily Metcalf, Kim Nguyen, Ryo Morisue, William W Ho, Ivy Chen, Brandon Sullivan, Leon H Yim, Arundeep Singh, Jiayu Fu und 8 weitere

Immunity · 2025-07 · 58 (7) · 1688-1705.e9

DOI: 10.1016/j.immuni.2025.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2025-07. Verfasst von Dig B Mahat und 19 weiteren Autor:innen. Beteiligte Einrichtung: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: mahat@mit.edu. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Suppressor Protein p53, Immune Checkpoint Inhibitors, Chemokine CXCL1. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsTumor Suppressor Protein p53Immune Checkpoint InhibitorsChemokine CXCL1Carcinoma, Pancreatic DuctalChemokinesHumansAnimalsMiceTumor MicroenvironmentGene Expression Regulation, NeoplasticCell Line, TumorEnhancer Elements, GeneticMutationNF-kappa BMutation, Missense

Stichwörter der Autor:innen

Cxcl1PDACPRO-seqchemokineenhancerimmune checkpoint inhibitorsmutant p53myeloid-derived suppressor cellsnascent RNA sequencingneutrophils

Substanzen

Tumor Suppressor Protein p53Immune Checkpoint InhibitorsChemokine CXCL1CXCL1 protein, humanChemokinesNF-kappa BTP53 protein, human

Autor:innen und Institutionen

  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: mahat@mit.edu.
  • Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Cambridge, MA 02139,…
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Ragon Institute of…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • GlaxoSmithKline
  • Nile Albright Research Foundation
  • Howard Hughes Medical Institute
  • National Institutes of Health
  • Ragon Institute of MGH, MIT and Harvard

Zitieren

APA

Mahat, D. B., Kumra, H., Castro, S. A., Metcalf, E., Nguyen, K., Morisue, R., Ho, W. W., Chen, I., Sullivan, B., Yim, L. H., Singh, A., Fu, J., Waterton, S. K., Cheng, Y. C., Moiso, E., Chauhan, V. P., Silva, H. M., Spranger, S., Jain, R. K., & Sharp, P. A. (2025). Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity, 58(7), 1688-1705.e9. https://doi.org/10.1016/j.immuni.2025.06.005

Vancouver

Mahat DB, Kumra H, Castro SA, Metcalf E, Nguyen K, Morisue R, et al. Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity. 2025;58(7):1688-1705.e9. doi:10.1016/j.immuni.2025.06.005

BibTeX
@article{Mahat2025,
  author = {Mahat, Dig B and Kumra, Heena and Castro, Sarah A and Metcalf, Emily and Nguyen, Kim and Morisue, Ryo and Ho, William W and Chen, Ivy and Sullivan, Brandon and Yim, Leon H and Singh, Arundeep and Fu, Jiayu and Waterton, Sean K and Cheng, Yu-Chi and Moiso, Enrico and Chauhan, Vikash P and Silva, Hernandez Moura and Spranger, Stefani and Jain, Rakesh K and Sharp, Phillip A},
  title = {Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer},
  journal = {Immunity},
  year = {2025},
  volume = {58},
  number = {7},
  pages = {1688--1705.e9},
  doi = {10.1016/j.immuni.2025.06.005}
}
Kostenlos starten →